Palmetto Health is using analytics to access controlled substance data in real time from a state-run Prescription Drug Monitoring Program, which records a patient’s opioid prescribing history, to identify usage patterns and those patients that are at potential risk for misuse or abuse.

Called NarxCare from analytics vendor Appriss, the substance use disorder platform automatically integrates with Palmetto’s Cerner electronic health record system analyzing PDMP and EHR data to assess and manage patient risk factors.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access